Prior Statin Therapy Is Associated With a Decreased Rate of Severe Sepsis
Top Cited Papers
- 17 August 2004
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 110 (7) , 880-885
- https://doi.org/10.1161/01.cir.0000138932.17956.f1
Abstract
Background— Statins have anti-inflammatory properties that are independent of their lipid-lowering abilities. We hypothesized that statin therapy before the onset of an acute bacterial infection may have a protective effect against severe sepsis. The aim of this study was to determine whether patients treated with statins develop severe sepsis less frequently. Methods and Results— In this prospective observational cohort study, consecutive patients admitted with presumed or documented acute bacterial infection were enrolled. The primary outcomes were the rate of severe sepsis and intensive care unit (ICU) admission. Of the 361 patients enrolled, 82 (22.7%) were treated with statins before their admission. Both groups had a similar severity of illness on admission. Severe sepsis developed in 19% of patients in the no-statin group and in only 2.4% of the statin group ( P P =0.025), reflecting a relative risk of ICU admission of 0.30 (95% CI, 0.1 to 0.95). Conclusions— Prior therapy with statins may be associated with a reduced rate of severe sepsis and ICU admission. If supported by prospective controlled trials, statins may have a role in the primary prevention of sepsis.Keywords
This publication has 37 references indexed in Scilit:
- HMG-CoA Reductase Inhibitor Simvastatin Profoundly Improves Survival in a Murine Model of SepsisCirculation, 2004
- Impact of sepsis-induced changes in plasma on LPS interactions with monocytes and plasma lipoproteins: roles of soluble CD14, LBP, and acute phase lipoproteinsInnate Immunity, 2003
- Impact of sepsis-induced changes in plasma on LPS interactions with monocytes and plasma lipoproteins: roles of soluble CD14, LBP, and acute phase lipoproteinsInnate Immunity, 2003
- The Pathophysiology and Treatment of SepsisNew England Journal of Medicine, 2003
- Anti-inflammatory and immunomodulatory effects of statinsKidney International, 2003
- The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune diseaseNature, 2002
- MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trialPublished by Elsevier ,2002
- The Effect of Statins on Mortality in Patients with BacteremiaClinical Infectious Diseases, 2001
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998
- Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of diseaseThe Lancet, 1994